Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01433302 · ClinicalTrials.gov registry record
Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 21
- Enrollment target
NCT01433302: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01433302 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01433302 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to measure the amount of inflammatory proteins inside the body before and after lymphatico-venular bypass surgery. This will help doctors learn if anti-fibrotic or anti-inflammatory drugs/treatments given with the surgery can improve how well the surgery works.
Interventions
- PROCEDURE Punch Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01433302
The ClinicalTrials.gov registry entry for NCT01433302 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Punch Biopsy is the first listed.
NCT01433302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01433302 about?
NCT01433302 is a clinical study titled "Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass". The goal of this clinical research study is to measure the amount of inflammatory proteins inside the body before and after lymphatico-venular bypass surgery. This will help doctors learn if anti-fibrotic or anti-inflammatory drugs/treatments given with the surgery can improve how well the surgery w...
What is the current status of trial NCT01433302?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2012-03. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01433302?
The interventions under investigation include: Punch Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01433302?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.